Jake Simson's most recent trade in Septerna Inc. was a trade of 16,623 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on June 17, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Septerna Inc. | Jake Simson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jun 2025 | 16,623 | 16,623 | - | - | Stock Option (Right to Buy) | |
| Janux Therapeutics Inc | Jake Simson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Jun 2025 | 11,667 | 11,667 | - | - | Stock Option (right to buy) | |
| Janux Therapeutics Inc | Jake Simson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Jun 2025 | 3,750 | 6,250 | - | 0 | Common Stock | |
| Bicara Therapeutics Inc. | Jake Simson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Jun 2025 | 23,746 | 23,746 | - | - | Stock Option (Right to Buy) | |
| Tyra Biosciences Inc | Jake Simson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 May 2025 | 22,200 | 22,200 | - | - | Stock Option (Right to Buy) | |
| Bicara Therapeutics Inc. | Jake Simson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Sep 2024 | 23,746 | 23,746 | - | - | Stock Option (Right to Buy) | |
| Janux Therapeutics Inc | Jake Simson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Jun 2024 | 8,350 | 8,350 | - | - | Stock Option (right to buy) | |
| Janux Therapeutics Inc | Jake Simson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Jun 2024 | 2,500 | 2,500 | - | 0 | Common Stock | |
| Tyra Biosciences Inc | Jake Simson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 May 2024 | 18,600 | 18,600 | - | - | Stock Option (Right to Buy) | |
| Janux Therapeutics Inc | Jake Simson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jun 2023 | 12,500 | 12,500 | - | - | Stock Option (right to buy) | |
| Tyra Biosciences Inc | Jake Simson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 May 2023 | 14,500 | 14,500 | - | - | Stock Option (Right to Buy) | |
| Janux Therapeutics Inc | Jake Simson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jun 2022 | 12,500 | 12,500 | - | - | Stock Option (right to buy) | |
| Tyra Biosciences Inc | Jake Simson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Jun 2022 | 14,500 | 14,500 | - | - | Stock Option (Right to Buy) | |
| Janux Therapeutics Inc | Jake Simson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jun 2021 | 30,000 | 30,000 | - | - | Stock Option (right to buy) |